Cyclodextrin-Based Gene and Drug Delivery Applications

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".

Deadline for manuscript submissions: 20 August 2024 | Viewed by 165

Special Issue Editors

E-Mail Website
Guest Editor

E-Mail Website
Guest Editor
Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
Interests: cyclodextrin; gene delivery; drug delivery; nanocarriers; biocompatibility; controlled release; targeted therapy

Special Issue Information

Dear Colleagues,

Cyclodextrins have emerged as versatile and promising materials in the field of drug delivery, owing to their unique structural properties and biocompatibility. The ability of cyclodextrins to form inclusion complexes with a wide range of guest molecules, including drugs and nucleic acids, has paved the way for innovative approaches in gene and drug delivery systems.

This Special Issue aims to showcase cutting-edge research, advancements, and applications of cyclodextrin-based delivery systems in the context of gene therapy and drug delivery. We welcome original research articles, reviews, and perspectives covering various aspects of this interdisciplinary field, including but not limited to the following:

  1. Design and synthesis of cyclodextrin-based carriers for gene and drug delivery;
  2. Formulation and characterization of cyclodextrin-based delivery systems;
  3. Applications of cyclodextrin-based carriers in targeted drug delivery;
  4. Cyclodextrin-based nanoparticles for gene delivery and therapy;
  5. In vitro and in vivo studies on the effectiveness of cyclodextrin-based delivery systems;
  6. Challenges and future perspectives in the development of cyclodextrin-based delivery systems.

Submitting your work to this Special Issue offers an excellent opportunity to contribute to the advancement of knowledge in this rapidly evolving area and to showcase your research to a global audience of peers and experts in the field. Furthermore, all submissions will undergo a rigorous peer-review process to ensure the highest quality of published content.

Prof. Dr. Francesco Trotta
Dr. Yousef Khazaei Monfared
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • cyclodextrin
  • gene delivery
  • drug delivery
  • nanocarriers
  • biocompatibility
  • controlled release
  • targeted therapy

Published Papers

This special issue is now open for submission.
Back to TopTop